We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Prods the FDA to Ease Criteria For Breakthrough Therapy Designation
PhRMA Prods the FDA to Ease Criteria For Breakthrough Therapy Designation
August 30, 2013
PhRMA is asking the FDA to broaden the criteria it uses for designating a drug as a breakthrough therapy to allow more candidates to win breakthrough status.